The lancet oncology

• Latest
• Best
• Search…

• The lancet oncology · Apr 2015

  Sunitinib benefits patients with small-cell lung cancer.

  no abstract available

  keep going… or just mark as read…

• The lancet oncology · Apr 2015

  Aromatase inhibitors may reduce endometrial cancer risk.

  no abstract available

  read more… mark as read…

• The lancet oncology · Apr 2015

  Correction to Lancet Oncol 2015; 16: 60, 61. Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multi-centre, single-arm, phase 2 study.

  no abstract available

  keep reading… mark as read…

• The lancet oncology · Apr 2015

  Comment

  Anti-emetics in paediatric patients receiving chemotherapy.

  no abstract available

  explore further… or just mark as read…

• The lancet oncology · Mar 2015

  Randomized Controlled Trial Multicenter Study Comparative Study

  Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240).

  GOG 240 was a practice-changing randomised phase 3 trial that concluded that chemotherapy plus bevacizumab for advanced cervical cancer significantly improves overall and progression-free survival, and the proportion of patients achieving an overall objective response, compared with chemotherapy alone. In this study, we aimed to analyse patient-reported outcomes in GOG 240. ⋯ National Institutes of Health.

  read more… or not…